Table 1 Characteristics of included studies
Study | Country | Design | Sample size | Mean age (years) | Men (%) | Follow up time (months) | Duration of dialysis (years) | Diabetes mellitus (%) | PAD (%) | Diagnosis of PAD | Events for analysis |
|---|---|---|---|---|---|---|---|---|---|---|---|
Fishbane et al. 1996 [8] | USA | PC | 132 | 61.5 | 59 | 12 | NA | 25.0 | 35.0 | ABI | AC/CV mortality |
Ono et al. 2003 [9] | Japan | PC | 1010 | 60.6 | 63.5 | 24 | 6.5 | 33.8 | 16.5 | ABI | AC/CV mortality |
Rajagopalan et al. 2006 [10] Vega et al. 2008 [17] | Multi-nation Spain | RC RC | 29873 220 | 61.4 62 | 57.7 56 | 64.8 47 | NA 5.8 | 37.7 21.4 | 25.3 40.5 | Clinical ssessment, history Clinical assessment, doooler | AC/CV mortality AC mortality |
Cohen et al. 2010 [11] | USA | PC | 512 | 61 | 55.9 | 6 | 19.8 | NA | 3.3 | NA | AC mortality |
Adragao et al. 2012 [12] | Portugal | PC | 219 | 65 | 60 | 36 | 6.8 | 20.0 | 41.0 | ABI, vascular calcification | AC/CV mortality |
Otsubo et al. 2012 [13] | Japan | RC | 86 | 59.8 | 69.8 | 105.6 | 15.1 | 19.8 | 22.1 | ABI | AC mortality |
Thani et al. 2013 [14] | Qatar | PC | 252 | 57 | 50.3 | 36 | 7.3 | 59.2 | 38.5 | ABI, Clinical assessment | AC mortality |
Tsai et al. 2015 [15] | Taiwan, China | RC | 444 | 61.6 | 46.4 | 79.2 | 7.7 | 32.7 | 24.8 | ABI | AC/CV mortality |
Zhou et al. 2015 [16] | China | PC | 116 | 56.4 | 53.4 | 72 | 7.1 | 9.5 | 18.0 | ABI, clinical assessment, history | AC/CV mortality |